Increasing Self Efficacy Behavior Prevention of Transmission and Compliance with Tuberculosis Medication through Health Promotion: A Systematic Review
DOI:
https://doi.org/10.33394/j-ps.v10i3.5321Keywords:
heath promotion, health education, self efficacy, tuberculosisAbstract
Self efficacy, behavior and compliance are very important factors in achieving optimal health status in pulmonary TB patients. Health promotion, improveself efficacy, transmission prevention behavior and adherence to taking TB drugs are some of the factors that can support the Tuberculosis control program. The purpose of this systematic review is to determine the effectiveness of health promotion toself-effi cacy, transmission prevention behavior and compliance with tuberculosis medication. Search for articles using the PICOT framework in the database; Ebscho, Science direct, Sage Journals, Scopus, Pubmed, restricted to the last 5 years; 2015 to 2020, there were 16 international journals. Journal design criteria used prospective study, cross sectional study and RCT. The number of samples from the study varied from 27 to 1.213 respondents. Based on the results of the study, there are six methods, namely conventional health promotion, health promotion training, digital health promotion training, online videos about tuberculosis, SMS and traditional language educational videos via DVD. The patient’s Self-efficacy can be seen when the patient has received digital health education and health promotion. On conventional methods and SMS can improve behavior and compliance, Prevention of transmission and adherence to taking medication in TB patients. The most effective method is using conventional methods that apply direct implementation or direct interaction between health promotion providers and participants.References
Adane, K., Spigt, M., Winkens, B., & Dinant, G.-J. (2019). Tuberculosis case detection by trained inmate peer educators in a resource-limited prison setting in Ethiopia: a cluster-randomised trial. The Lancet. Global Health, 7(4), e482–e491. https://doi.org/10.1016/S2214-109X(18)30477-7
Akram, A. (2020). Tuberculosis-Induced Bronchiectasis Complicated by Recurrent Respiratory Tract Infections and Renal Amyloidosis: A Classic Revisited. Cureus, 12(11), 9–13. https://doi.org/10.7759/cureus.11638
Ali, S. M., Naureen, F., Noor, A., Fatima, I., Viney, K., Ishaq, M., Anjum, N., Rashid, A., Haider, G. R., Khan, M. A., & Aamir, J. (2018). Loss-to-follow-up and delay to treatment initiation in Pakistan’s national tuberculosis control programme. BMC Public Health, 18(1), 335. https://doi.org/10.1186/s12889-018-5222-2
Bediang, G., Stoll, B., Elia, N., Abena, J.-L., & Geissbuhler, A. (2018). SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial. BMC Public Health, 18(1), 583. https://doi.org/10.1186/s12889-018-5502-x
Bisallah, C. I., Rampal, L., Lye, M.-S., Mohd Sidik, S., Ibrahim, N., Iliyasu, Z., & Onyilo, M. O. (2018). Effectiveness of health education intervention in improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria - A randomized control trial. PloS One, 13(2), e0192276. https://doi.org/10.1371/journal.pone.0192276
Caminero, J. A., Cayla, J. A., GarcÃa-GarcÃa, J.-M., GarcÃa-Pérez, F. J., Palacios, J. J., & Ruiz-Manzano, J. (2017). Diagnosis and Treatment of Drug-Resistant Tuberculosis. Archivos de Bronconeumologia, 53(9), 501–509. https://doi.org/10.1016/j.arbres.2017.02.006
Chipare, M. A., Tapera, R., Pachawo, R. F., & January, J. (2020). Exploring the evolution of health promotion in Namibia: opportunities and obstacles during the post-independence era. Global Health Promotion, 27(4), 107–113. https://doi.org/10.1177/1757975920938765
Galloway, R. D. (2003). Health promotion: causes, beliefs and measurements. Clinical Medicine & Research, 1(3), 249–258. https://doi.org/10.3121/cmr.1.3.249
Gao, J., Cook, V. J., & Mayhew, M. (2018). Preventing Tuberculosis in a Low Incidence Setting: Evaluation of a Multi-lingual, Online, Educational Video on Latent Tuberculosis. Journal of Immigrant and Minority Health, 20(3), 687–696. https://doi.org/10.1007/s10903-017-0601-9
Gashu, K. D., Gelaye, K. A., Lester, R., & Tilahun, B. (2021). Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trial. BMJ Health & Care Informatics, 28(1). https://doi.org/10.1136/bmjhci-2020-100268
Getahun, H., Matteelli, A., Abubakar, I., Abdel Aziz, M., Baddeley, A., Barreira, D., Den Boon, S., Gutierrez, S. M. B., Bruchfeld, J., Burhan, E., Cavalcante, S., Cedillos, R., Chaisson, R., Chee, C. B. E., Chesire, L., Corbett, E., Dara, M., Denholm, J., De Vries, G., … Raviglione, M. (2015). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, 46(6), 1563–1576. https://doi.org/10.1183/13993003.01245-2015
Gill, C. M., Dolan, L., Piggott, L. M., & McLaughlin, A. M. (2022). New developments in tuberculosis diagnosis and treatment. Breathe, 18(1), 1–15. https://doi.org/10.1183/20734735.0149-2021
Hwang, W. J., & Kim, M. J. (2020). Risk Perception & Risk-Reduction Behavior Model for Blue-Collar Workers: Adapted From the Health Promotion Model. Frontiers in Psychology, 11(November). https://doi.org/10.3389/fpsyg.2020.538198
Kebede, A., & Wabe, N. T. (2012). Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west ethiopia. North American Journal of Medical Sciences, 4(2), 67–71. https://doi.org/10.4103/1947-2714.93376
Kerr, E. M., Vonnahme, L. A., & Goswami, N. D. (2020). Impact of Targeted Local Interventions on Tuberculosis Awareness and Screening Among Persons Experiencing Homelessness During a Large Tuberculosis Outbreak in Atlanta, Georgia, 2015-2016. Public Health Reports (Washington, D.C. : 1974), 135(1_suppl), 90S-99S. https://doi.org/10.1177/0033354920932644
Kiazyk, S., & Ball, T. B. (2017). Latent tuberculosis infection: An overview. Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada, 43(3–4), 62–66. https://doi.org/10.14745/ccdr.v43i34a01
Kliiman, K., & Altraja, A. (2010). Predictors and mortality associated with treatment default in pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 14(4), 454–463.
Lester, R., Park, J. J. H., Bolten, L. M., Enjetti, A., Johnston, J. C., Schwartzman, K., Tilahun, B., & Delft, A. von. (2019). Mobile phone short message service for adherence support and care of patients with tuberculosis infection: Evidence and opportunity. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 16, 100108. https://doi.org/https://doi.org/10.1016/j.jctube.2019.100108
Massey, P. D., Asugeni, R., Wakageni, J., Kekeubata, E., Maena’aadi, J., Laete’esafi, J., Waneagea, J., Asugeni, V., MacLaren, D., & Speare, R. (2015). Steps on a journey to TB control in Solomon Islands: a cross-sectional, mixed methods pre-post evaluation of a local language DVD. BMC International Health and Human Rights, 15(1), 1. https://doi.org/10.1186/s12914-015-0041-3
Muñoz, L., Stagg, H. R., & Abubakar, I. (2015). Diagnosis and Management of Latent Tuberculosis Infection. Cold Spring Harbor Perspectives in Medicine, 5(11), a017830. https://doi.org/10.1101/cshperspect.a017830
Pablos-Méndez, A., Knirsch, C. A., Barr, R. G., Lerner, B. H., & Frieden, T. R. (1997). Nonadherence in tuberculosis treatment: predictors and consequences in New York City. The American Journal of Medicine, 102(2), 164–170. https://doi.org/10.1016/s0002-9343(96)00402-0
Spruijt, I., Haile, D. T., Erkens, C., van den Hof, S., Goosen, S., ten Kate, A., Teshome, H., Karels, M., Koenders, M., & Suurmond, J. (2020). Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans. BMC Public Health, 20(1), 315. https://doi.org/10.1186/s12889-020-8390-9
Thomas, T. A. (2017). Tuberculosis in Children. Pediatric Clinics of North America, 64(4), 893–909. https://doi.org/10.1016/j.pcl.2017.03.010
Tola, H. H., Shojaeizadeh, D., Tol, A., Garmaroudi, G., Yekaninejad, M. S., Kebede, A., Ejeta, L. T., Kassa, D., & Klinkenberg, E. (2016). Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial. PloS One, 11(5), e0155147. https://doi.org/10.1371/journal.pone.0155147
Tomey, M, A & Alligood, R, M. (2010). Nursing Theorists and Their Work. 7Ed (p. Mosby. Elsevier).
Zare, M. F. R., Asadi, Z., Shahroodi, M. V., & Bahrami-Taghanaki, H. (2017). Investigating the Relationship between Components of Pender’s Health Promotion Model and Self-care Behaviors among Patients with Smear-positive Pulmonary Tuberculosis. Evidence Based Care, 6, 7–17.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution 4.0 International License.